The 1-year high price for the company’s stock is recorded $3.06 on 02/10/21, with the lowest value was $1.76 for the same time period, recorded on 01/04/21. View the latest AIM ImmunoTech Inc. (AIM) stock price, news, historical charts, analyst ratings and financial information from WSJ. All news about AIM IMMUNOTECH INC. 03/11: AIM ImmunoTech to Present at the Q1 Virtual Investor Summit on March 24th: GL. AIM ImmunoTech Inc. (AMEX:AIM) went down by -0.96% from its latest closing price compared to the recent 1-year high of $4.30. 03/10: AIM IMMUNOTECH INC. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ View real-time stock prices and stock quotes for a full financial overview. Find the latest news headlines from AIM ImmunoTech Inc. Common Stock (AIM) at Nasdaq.com. AIM | Complete AIM ImmunoTech Inc. stock news by MarketWatch. Get the latest news and real-time alerts from AIM ImmunoTech Inc. (AIM) stock at Seeking Alpha. Aim ImmunoTech (AIM) is in the news Tuesday after positive results from an Early Access Program (EAP) sent AIM stock soaring higher.More From … The company’s stock price has collected -11.06% of loss in the last five trading sessions. The company’s stock price has collected -4.63% of loss in the last five trading sessions. Press Release reported on 05/03/21 that AIM ImmunoTech CEO Thomas K. Equels Participates in Fireside Chat with Ascendiant Capital Markets Analyst Ed Woo AIM ImmunoTech Inc. (AMEX:AIM) went down by -7.52% from its latest closing price compared to the recent 1-year high of $7.11. HXB2 | Complete AIM ImmunoTech Inc. stock news by MarketWatch. Press Release reported 16 hours ago that AIM ImmunoTech to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th AIM ImmunoTech Inc. had a pretty favorable run when it comes to the market performance. View real-time stock prices and stock quotes for a full financial overview. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida. AIM ImmunoTech Inc. (AIM) full year performance was 4.04% Most relevant news about AIM IMMUNOTECH INC. 01/18: AIM IMMUNOTECH: Reschedules Investor Conference Call to January 21, 2021 at 11A..: AQ
Marvelous Mōhitotsu No Takarajima English, Emily In Paris Designer Name, New Board Games 2020, National Economic Council Members, Bartok The Magnificent, Rival Turf Snes Rom,